ClinicalTrials.gg
Not yet recruitingNCT07935577Updated Nov 17, 2026

Effect of a Confidence-Building and Diaphragmatic Breathing-Assisted Graded Exposure on Kinesiophobia and Anxiety During First Mobilization Among Women After Cesarean Section

An interventional study of Confidence Building and Diaphragmatic Breathing -Assisted Graded Exposure in Kinesiophobia, Anxiety and Post-Cesarean Recovery, sponsored by Ghadeer Fadhel Abbas. Not yet recruiting. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Ghadeer Fadhel Abbas · Not applicable, Interventional, and Supportive care

Updated Nov 17, 2026Eligibility revisedNewly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Non-randomized
Ages
18 Years and older
Sex
Female
01

Study summary

This quasi-experimental study will evaluate whether a program combining confidence building, diaphragmatic breathing (slow, deep belly breathing), and gradual exposure to movement can reduce fear of movement and anxiety during first mobilization after cesarean section.

The study will include two groups without random assignment. The intervention group will receive the combined program in addition to routine hospital care. The control group will receive routine hospital care only. Fear of movement and anxiety will be assessed before and after the intervention period in both groups. Changes will be compared between the groups to evaluate the effects of the program.

02

Conditions studied

  • Kinesiophobia
  • Anxiety
  • Post-Cesarean Recovery

Keywords

  • Cesarean Section
  • First Mobilization
  • Confidence Building
  • Diaphragmatic Breathing
  • Graded Exposure
03

In context

Kinesiophobia

287 studies on the registry are indexed under Kinesiophobia; 92 are open to participants now.

This study's planned enrollment of 60 is above the median of 52 across 176 interventional studies indexed under Kinesiophobia.

Browse Kinesiophobia studies →

Lead sponsor

This is the only study on the registry with Ghadeer Fadhel Abbas as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

The criteria were revised on the registry on Nov 17, 2026. See what changed

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women aged 18 years or older who have undergone cesarean section.
  • Women who are medically stable and approved by the responsible healthcare team for first mobilization.
  • Women who have not yet started their first out-of-bed mobilization at the time of baseline assessment.
  • Women who are able to understand the intervention instructions, communicate with the researcher, and complete the study assessment tools.
  • Women who are willing to participate and provide written .

Exclusion criteria

Exclusion Criteria :

  • Medical instability or a clinical to first mobilization.
  • Severe postoperative complications that prevent safe mobilization.
  • Neurological or musculoskeletal disorders that substantially impair the ability to stand or walk safely.
  • Cognitive or communication difficulties that prevent understanding the intervention or valid completion of the study assessment tools.
  • A severe psychiatric condition that substantially interferes with , participation in the intervention, or valid completion of the study assessments, as determined according to the approved study protocol.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Confidence-Building and Breathing-Assisted Graded Exposure Group

    Behavioral: Confidence Building and Diaphragmatic Breathing -Assisted Graded Exposure

  • No intervention
    Routine Care Control Group

Interventions

  • BehavioralConfidence Building and Diaphragmatic Breathing -Assisted Graded Exposure

    The researcher will deliver the program in addition to routine hospital care after the clinical team confirms that the woman is medically stable and cleared for first mobilization after cesarean section. Confidence building will include supportive discussion (approximately 5 minutes) to identify concerns, explain the movement sequence, and provide realistic reassurance and encouragement. Guided mental rehearsal (approximately 10 minutes) will help the woman mentally prepare for sitting, standing, and walking. This will be followed by 3 minutes of slow, comfortable diaphragmatic breathing without straining the surgical area. Graded exposure-assisted mobilization will progress through five levels: in-bed position adjustment, upright sitting, sitting at the bedside, supported standing, and short assisted walking. Each level will be attempted according to clinical stability and tolerance, with positive feedback after successful completion.

06

What researchers measure

Primary outcomes

  1. Change in Kinesiophobia Measured by the Tampa Scale for Kinesiophobia (TSK-17)

    kinesiophobia will be assessed in both groups using the 17-item Tampa Scale for Kinesiophobia (TSK-17). Total scores range from 17 to 68, with higher scores indicating greater fear of movement. Changes from baseline to the post-intervention assessment will be compared between the intervention and control groups.

    Time frame: Baseline before the intervention and first mobilization, and immediately after completion of first mobilization; the same assessment timing will apply to both groups.

Secondary outcomes

  1. Change in Anxiety Measured by the Visual Analogue Scale for Anxiety (VAS-A)

    Anxiety will be assessed in both groups using a 100-mm Visual Analogue Scale for Anxiety (VAS-A), ranging from 0 (no anxiety) to 100 (worst imaginable anxiety). Higher scores indicate greater anxiety. Changes from baseline to the post-intervention assessment will be compared between the intervention and control groups.

    Time frame: Baseline before the intervention and first mobilization, and immediately after completion of first mobilization; the same assessment timing will apply to both groups

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Bandura, A. (1997). Self-efficacy: The exercise of control. W. H. Freeman. Gonella, S., Delfino, C., Rolfo, M., Rizzo, A., Esposito, V., Berchialla, P., & Campagna, S. (2021). Effects of a video-based preoperative educational intervention plus nurse-led reinforcement discussion on knowledge, self-efficacy, and resilience in patients undergoing major surgery. Clinical Nursing Research, 30(6), 753-761. https://doi.org/10.1177/1054773820986916 Peng, J., Luo, Y., Feng, L., Xiao, J., Feng, F., Zheng, Y., Bao, L., Yang, S., & Wu, X. (2025). Targeting kinesiophobia after thoracic surgery with an integrated protection motivation and exposure intervention: A randomized controlled trial. Journal of Pain Research, 18, 6911-6920. https://doi.org/10.2147/JPR.S544205 Prokopowicz, A., & Byrka, K. (2021). Effectiveness of mental simulations on the early mobilization of patients after cesarean section: A randomized controlled trial. Scientific Reports, 11, 22634. https://doi.org/10.1038/s41598-021-02036-1 Rittharomya, J., Krua-aum, P., & Aree-Ue, S. (2025). Effectiveness of a rehabilitation self-efficacy program on postoperative outcomes in older adults with hip fracture: A randomized controlled trial. Pacific Rim International Journal of Nursing Research, 29(1), 91-107. https://doi.org/10.60099/prijnr.2025.269063 Watson, G. M., Sutherland, J., Lacey, C., & Bridgman, P. G. (2022). A randomised crossover trial of QT response to hyperventilation-induced anxiety and diaphragmatic breathing in patients with stress cardiomyopathy and in control patients. PLoS ONE, 17(3), e0265607. https://doi.org/10.1371/journal.pone.0265607

Individual participant data

Plan to share: Undecided

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Feb 2027, 3 months later.

Of 133 non-industry interventional studies with no phase under Kinesiophobia, half reached primary completion within 8 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 14. This study's planned 3 months is below that.

Counting every sponsor, half of 133 studies reached it within 8 months; a quarter within 4 and three quarters within 14.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 9, 2026
First posted
Nov 13, 2026
StartEst.
Nov 22, 2026
Primary completionEst.
Feb 2027
CompletionEst.
Feb 2027
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Eligibility
1 inclusion criterion edited; 2 exclusion criteria edited, 1 added; 1 criterion removed
What changed in the criteria
  • Removed-
Inclusion criteria
  • EditedInclusion Criteria:Women aged 18 years or older who have undergone cesarean section.
Exclusion criteria
  • EditedExclusion Criteria : Medical instability or a clinical contraindication to first mobilization.
  • AddedSevere postoperative complications that prevent safe mobilization.
  • Edited7. Severe postoperative complications that prevent safe mobilization. 8. Neurological or musculoskeletal disorders that substantially impair the ability to stand or walk safely.
Nov 17, 2026
Registered
First appeared on the registry
Nov 13, 2026
Show all 2 updates
  1. Nov 17, 2026
    Eligibility 1 inclusion criterion edited; 2 exclusion criteria edited, 1 added; 1 criterion removed
    What changed in the criteria
    • Removed-
    Inclusion criteria
    • EditedInclusion Criteria:Women aged 18 years or older who have undergone cesarean section.
    Exclusion criteria
    • EditedExclusion Criteria : Medical instability or a clinical contraindication to first mobilization.
    • AddedSevere postoperative complications that prevent safe mobilization.
    • Edited7. Severe postoperative complications that prevent safe mobilization. 8. Neurological or musculoskeletal disorders that substantially impair the ability to stand or walk safely.
    + 2 other changes: index terms and conditions
  2. Nov 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07935577
Lead sponsor
Ghadeer Fadhel Abbas
Responsible party
Ghadeer Fadhel Abbas (Master's student, Karbala University) — Sponsor-investigator
First posted
Nov 13, 2026
Start date
Nov 22, 2026 (estimated)
Primary completion
Feb 2027 (estimated)
Completion
Feb 2027 (estimated)
Last update
Nov 17, 2026

Study contacts

Ghadeer F Abbas
Contact
ghadeer.f@s.uokerbala.edu.iq
+9647808020105

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion